Hi everyone,
We welcome you to join a virtual AOM symposium on innovation strategy, more specifically on Corporate R&D.
Firms in knowledge-intensive industries create important intellectual assets while also aiming to appropriate value from their innovation. Survey-based research highlights that firms prefer secrecy and lead time over other appropriation methods (e.g., patents and scientific papers) in order to profit from their intellectual assets. However, firms frequently choose to disclose their intellectual assets via patenting and scientific publications. This symposium illuminates specific channels which guide firms' R&D disclosure strategies. The studies in this symposium focus on the private incentives and performance implications for firms that share their valuable knowledge in the public domain. R&D disclosure choices create competitive implications for other stakeholders, potentially changing innovation trajectories of entire industries. The four studies in this symposium analyze antecedents and consequences of corporate R&D disclosure in various sectors such as the medical device industry and Artificial Intelligence using advanced empirical techniques ranging from the synthetic control method to difference-in-differences. The studies in this symposium contribute to the innovation strategy literature concerned with strategic interactions of innovating firms.Presenters: Deepak Hegde,
NYU SternSharon Belenzon and
Larisa Cristina Cioaca,
Duke Fuqua Raffaele Conti; ESSEC Business School
Nur Ahmed, MIT Sloan
Romel Mostafa, Ivey Business School
Discussants:
David Hsu, Wharton
Hong Luo, Harvard Business School
Organizers:
Aldona Kapacinskaite, Bocconi University
Nur Ahmed, MIT Sloan
Date & Time: August 8, 11:30 AM (EST) or 8:30 AM (Seattle time)
AOM Link: https://2022.aom.org/meetings/virtual/FnbFtke7ThkcBCn9G Please let us (
nurahmed@mit.edu) know if you have any questions.
best,
Nur Ahmed
------------------------------
Nur Ahmed
Postdoc, MIT Sloan
https://www.nurahmed.com/------------------------------